Anaplastic lymphoma kinase (ALK) rearrangement-positive lung cancer is a subtype of lung cancer and accounts for approximately 5% of the total non-small cell lung cancers (NSCLC) driven by a genetic alteration of the ALK gene [1–5]. The gene discussed is ALK; the disease is lung cancer.